Illuccix (kit for Ga-68 gozetotide)
Telix's ready-to-label kit that lets any nuclear medicine department make the gallium PSMA scan for prostate cancer.
Overview
Illuccix was approved by the FDA in December 2021 for PET imaging of PSMA-positive lesions in men with suspected metastasis who are candidates for definitive therapy and in men with suspected recurrence based on rising PSA, and in 2025 the label was extended to selecting patients for PSMA radioligand therapy. Gozellix, a second-generation kit with longer post-labelling shelf life, was approved in 2025. Illuccix is also registered in Australia and several other markets. The kit format made PSMA PET available to centres without access to the cyclotron-produced 18F tracers.
Approvals
| Region | Year | Indication |
|---|---|---|
| US | 2021 | PSMA PET imaging in prostate cancer (initial staging with suspected metastasis; suspected recurrence) |
| Australia | 2021 | PSMA PET imaging in prostate cancer |
| US | 2025 | Gozellix kit; selection of patients for PSMA-targeted radioligand therapy |
Trials
topRecruiting now (live from ClinicalTrials.gov)
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Notes
top- What a result means: PSMA-avid spots on the scan indicate prostate cancer deposits and decide between local treatment, systemic therapy or radioligand therapy.
Latest papers
topQuery for this drug: (TITLE:"Illuccix" OR ABSTRACT:"Illuccix" OR TITLE:"kit for Ga-68 gozetotide" OR ABSTRACT:"kit for Ga-68 gozetotide" OR TITLE:"Gozellix" OR ABSTRACT:"Gozellix") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Illuccix (kit for Ga-68 gozetotide), not a curated reading list.
Pages like this
not linked directly; found by shared links- ProductFludeoxyglucose F-18 (FDG)
Shares PET/CT and the tag test.
- ProductPaige Prostate Detect
Shares Prostate cancer and the tag test.
- ProductOncotype DX Genomic Prostate Score
Shares Prostate cancer and the tag test.
- ProductProlaris
Shares Prostate cancer and the tag test.
- ProductBRACAnalysis CDx
Shares Prostate cancer and the tag test.
- PairingPSMA PET → PSMA radioligand therapy
Shares Piflufolastat F-18 / Pylarify TruVu, Theranostics, Lutetium-177 vipivotide tetraxetan, PSMA.
- CompanyClarity Pharmaceuticals
Shares Theranostics, PSMA, PSMA PET, Prostate cancer.
- PersonLouise Emmett
Shares Lutetium-177 vipivotide tetraxetan, PSMA, PSMA PET, Prostate cancer.